Novel combinations to improve hematopoiesis in myelodysplastic syndrome

Myelodysplastic syndrome (MDS) represents a heterogeneous group of clonal hematopoietic disorders, which is characterized by cytopenias in the peripheral blood and bone marrow dysplasia due to ineffective hematopoiesis. Patients with MDS have an increased risk of transformation to acute myeloid leuk...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Khaja, Naguib, Sara, Liu, Zhao-Jun, Cimmino, Luisa, Yang, Feng-Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083030/
https://www.ncbi.nlm.nih.gov/pubmed/32197634
http://dx.doi.org/10.1186/s13287-020-01647-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083030/
https://www.ncbi.nlm.nih.gov/pubmed/32197634
http://dx.doi.org/10.1186/s13287-020-01647-1

Ejemplares similares